IRIS
PELIZZARI, GIACOMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.758
AS - Asia 1.529
EU - Europa 797
SA - Sud America 194
AF - Africa 45
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.326
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.696
SG - Singapore 741
CN - Cina 266
VN - Vietnam 174
IT - Italia 159
BR - Brasile 151
HK - Hong Kong 139
DE - Germania 117
RU - Federazione Russa 89
UA - Ucraina 72
FR - Francia 64
GB - Regno Unito 62
IN - India 54
FI - Finlandia 42
IE - Irlanda 40
CA - Canada 39
BD - Bangladesh 33
BE - Belgio 25
PL - Polonia 21
TR - Turchia 19
SE - Svezia 18
AR - Argentina 15
ES - Italia 15
JP - Giappone 15
IQ - Iraq 14
MX - Messico 14
NL - Olanda 14
AT - Austria 13
KR - Corea 12
ZA - Sudafrica 12
CZ - Repubblica Ceca 9
ID - Indonesia 9
MA - Marocco 9
EC - Ecuador 7
IR - Iran 7
VE - Venezuela 7
EG - Egitto 6
LT - Lituania 6
UZ - Uzbekistan 6
CO - Colombia 5
HU - Ungheria 5
SA - Arabia Saudita 5
CL - Cile 4
LV - Lettonia 4
PH - Filippine 4
PK - Pakistan 4
RO - Romania 4
IL - Israele 3
KE - Kenya 3
LB - Libano 3
TG - Togo 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BO - Bolivia 2
BY - Bielorussia 2
ET - Etiopia 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
MN - Mongolia 2
NI - Nicaragua 2
NP - Nepal 2
OM - Oman 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
AU - Australia 1
BB - Barbados 1
BS - Bahamas 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
GN - Guinea 1
GP - Guadalupe 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
KZ - Kazakistan 1
LY - Libia 1
MG - Madagascar 1
MM - Myanmar 1
MT - Malta 1
MU - Mauritius 1
MY - Malesia 1
MZ - Mozambico 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PY - Paraguay 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 6.323
Salva come PNG Salva come JPEG
Città #
Ashburn 454
Singapore 346
Fairfield 304
Chandler 230
San Jose 213
Ann Arbor 145
Beijing 143
Hong Kong 136
Woodbridge 136
Houston 131
Seattle 123
Chicago 121
Wilmington 111
Los Angeles 110
Cambridge 99
Council Bluffs 78
New York 71
Boardman 67
Lauterbourg 48
Salt Lake City 46
Princeton 44
Dong Ket 41
Dallas 38
Dublin 38
Hanoi 37
Ho Chi Minh City 36
Jacksonville 36
Munich 35
Dearborn 34
Buffalo 32
Santa Clara 31
San Diego 28
Frankfurt am Main 26
Brussels 25
Helsinki 24
Montreal 24
Elk Grove Village 20
Redondo Beach 18
Warsaw 18
Ogden 17
Tampa 17
The Dalles 17
Redmond 16
São Paulo 16
Martignacco 15
Milan 15
Tokyo 15
Izmir 13
Lancaster 13
London 13
Washington 13
Chennai 12
Denver 12
Newark 12
Poplar 12
Udine 12
Brooklyn 11
Orem 11
Turku 11
Des Moines 10
Miami 10
Sterling 10
Hefei 9
Seoul 9
Düsseldorf 8
Nuremberg 8
Phoenix 8
Stockholm 8
Toronto 8
Baghdad 7
Johannesburg 7
Leawood 7
Manchester 7
San Francisco 7
Vienna 7
Ardabil 6
Augusta 6
Biên Hòa 6
Brno 6
Charlotte 6
Da Nang 6
Mexico City 6
Pittsburgh 6
Boston 5
Cairo 5
City of London 5
Detroit 5
Dulles 5
Hải Dương 5
Lappeenranta 5
Marseille 5
Mumbai 5
Norwalk 5
Rome 5
Salvador 5
Tashkent 5
Trieste 5
Amsterdam 4
Belo Horizonte 4
Caracas 4
Totale 4.230
Salva come PNG Salva come JPEG
Nome #
Immunotherapy in NSCLC Patients with Brain Metastases 458
The SLICE study: The prognostic role of visceral fat in metastatic colorectal cancer 222
Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for A Cost-Effective and Dynamic Biomarker 195
Comparison of primary breast cancer and paired metastases: biomarkers discordance influence on outcome and therapy 184
Neutrophil-to-lymphocyte and lymphocyte-to-monocyte ratios in breast cancer 184
Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to Bedside 181
Androgen receptor in estrogen receptor positive breast cancer: Beyond expression 175
Prognostic role of disease extent and lymphocyte-monocyte ratio in advanced melanoma 165
Prognostic role of disease extent and lymphocyte-monocyte ratio in advanced melanoma 155
A risk score integrating lymphocytes ratios (LRs) and lactate dehydrogenase (LDH) levels to predict prognosis in metastatic breast cancer (MBC) patients 153
Do platinum salts fit all triple negative breast cancers? 151
The role of sidedness in second-line therapy for RAS wild-type colorectal cancer: a network meta-analysis (NMA) 151
Central nervous system involvement in breast cancer patients: Is the therapeutic landscape changing too slowly? 146
Monocyte-to-lymphocyte ratio in metastatic colorectal cancer: Prognostic role evaluation and cut-off definition 145
Controversies in monitoring metastatic breast cancer during systemic treatment. Results of a GIM (Gruppo Italiano Mammella) survey 142
Monitoring metastatic breast cancer (M-MBC) during treatment: a GIM (Gruppo Italiano Mammella) survey 141
Determinants of oncologist's choice in offering drug holidays during first line therapy for patients with metastatic colorectal cancer 140
Small luminal-like breast cancer: determinants of adjuvant chemotherapy use 136
Atezolizumab for the treatment of breast cancer 135
The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patients 131
Pertuzumab and breast cancer: another piece in the anti-HER2 puzzle 128
Hype or hope? The strange case of platinum salts’ renaissance in breast cancer 127
Biologically driven cut-off definition of lymphocyte ratios in metastatic breast cancer and association with exosomal subpopulations and prognosis 126
Lactate dehydrogenase as a prognostic biomarker in patients with hormone receptor-positive metastatic breast cancer treated with palbociclib: An exploratory cohort study 126
Platinum Salts in Patients with Breast Cancer: A Focus on Predictive Factors 124
Neutrophil-to-lymphocyte ratio in metastatic breast cancer patients: relationship with tumor characteristics and survival 119
Feasibility and Predictive Performance of a Triage System for Patients with Cancer During the COVID-19 Pandemic 114
Bevacizumab or PARP-Inhibitors maintenance therapy for platinum-sensitive recurrent ovarian cancer: A network meta-analysis 113
Management optimization of non small cell lung cancer (NSCLC) specimens. A single institution experience with a multiplexed mass spectrometry approach 111
The MIMIC Study: Prognostic Role and Cutoff Definition of Monocyte-to-Lymphocyte Ratio and Lactate Dehydrogenase Levels in Metastatic Colorectal Cancer 111
Post-neoadjuvant strategies in breast cancer: From risk assessment to treatment escalation 108
Platinum-Based Chemotherapy in Older Patients with Non-Small Cell Lung Cancer: What to Expect in the Real World 104
Simultaneous quantification of palbociclib, ribociclib and letrozole in human plasma by a new LC-MS/MS method for clinical application 102
A new dried blood spot LC-MS/MS method for therapeutic drug monitoring of palbociclib, ribociclib, and letrozole in patients with cancer 100
Determinants of choice in offering drug holidays during first-line therapy for metastatic colorectal cancer 96
Non-small cell lung cancer harboring EGFR G724S mutation and exon 19 deletion responded to afatinib monotherapy after multiple lines of target therapies 95
T-DM1 versus pertuzumab, trastuzumab and a taxane as first-line therapy of early-relapsed HER2-positive metastatic breast cancer: an Italian multicenter observational study 92
Clinico-radiological monitoring strategies in patients with metastatic breast cancer: a real-world study 89
Antibody–Drug Conjugates in Non-Small Cell Lung Cancer: State of the Art and Future Perspectives 87
Prognostic role of visceral fat for overall survival in metastatic colorectal cancer: A pilot study 87
The Role of ctDNA in the Management of Non-Small-Cell Lung Cancer in the AI and NGS Era 86
Alectinib for the treatment of papillary thyroid carcinoma harbouring STRN – ALK fusion 85
Drug holidays and overall survival of patients with metastatic colorectal cancer 84
Prediction, prevention, and precision treatment of immune checkpoint inhibitor neurological toxicity using autoantibodies, cytokines, and microbiota 84
Final results from CAMEO-PRO study: complementary and alternative medicine in oncology. physicians inform oncological patients 81
First-line platinum-based chemotherapy in elderly patients with NSCLC: determinants of therapeutic choice and outcome 79
An Italian Delphi study to evaluate consensus on adjuvant endocrine therapy in premenopausal patients with breast cancer: The ERA project 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis 11 Medical and Health Sciences 1103 Clinical Sciences 73
First- and second-line treatment strategies for hormone-receptor (HR)-positive HER2-negative metastatic breast cancer: A real-world study 71
Strategy of monitoring metastatic breast cancer (M-MBC) in clinical practice: more or less intensive? 69
Estimating survival in patients with melanoma brain metastases: prognostic value of lactate dehydrogenase 64
Second-line treatment strategies for RAS wild-type colorectal cancer: A systematic review and Network Meta-analysis (NMA) 61
Totale 6.486
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.157
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.157
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022391 33 46 2 7 6 17 28 23 4 57 120 48
2022/2023486 51 58 12 59 57 111 4 36 63 7 20 8
2023/2024301 24 10 19 10 54 103 2 14 23 15 1 26
2024/20251.013 25 56 38 60 74 48 78 53 124 98 131 228
2025/20262.666 342 460 126 253 389 197 253 93 182 178 131 62
2026/202767 67 0 0 0 0 0 0 0 0 0 0 0
Totale 6.486